Site icon Dailybn

Blood Irradiator Devices Market Size, Business Strategies, Product Sales and Growth Rate, Assessment to 2027

Global Blood Irradiator Devices Market: Introduction

According to the Atomic Energy Regulation Board (AERB), self-contained dry source storage gamma irradiators are also known by commercial names such as gamma irradiation chambers (GIC), gamma chambers, blood irradiators (BI), or gamma cells. Gamma irradiation chambers are used in hospitals and blood banks for irradiation of blood and blood products/components, and for clinical and research purposes.

View Report :   https://www.transparencymarketresearch.com/blood-irradiator-devices-market.html

Blood irradiator is a type of gamma irradiation chamber. Irradiation of blood & blood products by gamma rays is a proven and safe method to eliminate the risk of post transfusion graft versus host disease. According to the American Association of Blood Banks (AABB), the cellular blood components are irradiated prior to transfusion to prevent the proliferation of viable T lymphocytes, which are the immediate cause of transfusion associated-graft versus host disease (TA-GVHD). Gamma irradiation of cellular blood components is the best current technology to reduce the risk of T-GVHD to the recipients as confirmed by research. Therefore, it is being widely practiced world over in hospitals and blood banks as a lifesaving approach to this problem. Blood is usually irradiated in standard blood bags in dedicated blood irradiators using cobalt-60 or caesium-137 radioactive source.

Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77174

Key Drivers of Global Blood Irradiator Devices Market

Complications of Blood Transfusion

Complications of blood transfusion are rare, but can be life threatening. Allergic reactions to blood received during a transfusion, even when given the right blood type, can be observed in some patients. In some cases, symptoms can include hives and itching. As in most allergic reactions, this can be treated with antihistamines. All donated blood is thoroughly tested for HIV. There is a 1 in 2 million chance that donated blood will not only carry HIV, but also infect a transfusion recipient. Hepatitis B. The odds of contracting hepatitis B from donated blood is about 1 in 300,000. The risk with hepatitis C is 1 in 1.5 million. According to the World Health Organization, of the 117.4 million blood donations collected globally, 42% are collected in high-income countries, home to 16% of the world’s population.

Increasing adoption of X-ray irradiators

The adoption of X-ray irradiators has reduced the risk significantly. The X-ray irradiators enhances the safety of the blood supply and increased the security of our facilities. The X-ray irradiator has also enabled to increase the performance and reliability. The usage and the adoption in the healthcare drives the market

North America to Account for Major Share of Global Blood Irradiator Devices Market

Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77174

Key Players Operating in Global Blood Irradiator Devices Market

The global blood irradiator devices market is highly consolidated, with the presence of a small number of key players. Leading players operating in the global blood irradiator devices market are:

Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Global Blood Irradiator Devices Market: Research Scope

Global Blood Irradiator Devices Market, by Product Type

Global Blood Irradiator Devices Market, by End-user

Global Blood Irradiator Devices Market, by Region

More Trending Reports by Transparency Market Research – 1.  https://www.prnewswire.com/news-releases/global-radiation-therapy-market-to-reach-us-8-6-bn-by-2026–product-approvals-to-drive-growth-transparency-market-research-300998453.html

2.  https://www.biospace.com/article/dna-test-kits-market-increase-in-demand-for-ancestry-testing-to-drive-market/

Exit mobile version